Search research articles
Contact Us
Filters
Showing results (31-40 of 91) with videos related to
Page
of 10
Sort By:
BMJ (Clinical Research Ed.)
|
February 7, 2012
Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis
Johanne Silvain, Farzin Beygui, Olivier Barthélémy, et al.
American Heart Journal
|
April 9, 2011
A comparison of prasugrel at the time of percutaneous coronary intervention or as pretreatment at the time of diagnosis in patients with non-ST-segment elevation myocardial infarction: design and rationale for the ACCOAST study
Gilles Montalescot, Leonardo Bolognese, Dariusz Dudek, et al.
Echocardiography (Mount Kisco, N.Y.)
|
March 27, 2007
Mid-ventricular ballooning heart syndrome
Jean Marc Aubert, Pierre Vladimir Ennezat, Olivier Tricot, et al.
American Heart Journal
|
September 21, 2015
Incidence and consequence of major bleeding in primary percutaneous intervention for ST-elevation myocardial infarction in the era of radial access: an analysis of the international randomized Acute myocardial infarction Treated with primary angioplasty and intravenous enoxaparin Or unfractionated heparin to Lower ischemic and bleeding events at short- and Long-term follow-up trial
Cyril Pellaton, Guillaume Cayla, Johanne Silvain, et al.
Journal of the American Heart Association
|
August 26, 2015
Infarct Size, Shock, and Heart Failure: Does Reperfusion Strategy Matter in Early Presenting Patients With ST-Segment Elevation Myocardial Infarction?
Jay Shavadia, Yinggan Zheng, Neda Dianati Maleki, et al.
Clinical Neurology and Neurosurgery
|
December 19, 2020
Impact of COVID-19 pandemic on patients with intracranial aneurysm rupture
Rabih Aboukaïs, Antoine Devalckeneer, Pierre Boussemart, et al.
Circulation. Cardiovascular Interventions
|
October 26, 2018
One-Year Survival After ST-Segment-Elevation Myocardial Infarction in Relation With Prehospital Administration of Dual Antiplatelet Therapy
Nicolas Danchin, Etienne Puymirat, Guillaume Cayla, et al.
American Heart Journal
|
November 7, 2015
Impact of prasugrel pretreatment and timing of coronary artery bypass grafting on clinical outcomes of patients with non-ST-segment elevation myocardial infarction: From the A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST-Elevation Myocardial Infarction (ACCOAST) study
Dariusz Dudek, Artur Dziewierz, Petr Widimsky, et al.
Archives of Cardiovascular Diseases
|
February 10, 2010
Functional decline in elderly patients presenting with acute coronary syndromes: impact on midterm outcome
Clémence Huerre, Aurélie Guiot, Sylvestre Maréchaux, et al.
Archives of Cardiovascular Diseases
|
July 27, 2010
Impact of polyvascular disease on baseline characteristics, management and mortality in acute myocardial infarction. The Alliance project
Anouk Meizels, David Messika Zeitoun, Vincent Bataille, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 91) with videos related to
Sort By:
Page
of 10
BMJ (Clinical Research Ed.)
|
February 7, 2012
Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis
Johanne Silvain, Farzin Beygui, Olivier Barthélémy, et al.
American Heart Journal
|
April 9, 2011
A comparison of prasugrel at the time of percutaneous coronary intervention or as pretreatment at the time of diagnosis in patients with non-ST-segment elevation myocardial infarction: design and rationale for the ACCOAST study
Gilles Montalescot, Leonardo Bolognese, Dariusz Dudek, et al.
Echocardiography (Mount Kisco, N.Y.)
|
March 27, 2007
Mid-ventricular ballooning heart syndrome
Jean Marc Aubert, Pierre Vladimir Ennezat, Olivier Tricot, et al.
American Heart Journal
|
September 21, 2015
Incidence and consequence of major bleeding in primary percutaneous intervention for ST-elevation myocardial infarction in the era of radial access: an analysis of the international randomized Acute myocardial infarction Treated with primary angioplasty and intravenous enoxaparin Or unfractionated heparin to Lower ischemic and bleeding events at short- and Long-term follow-up trial
Cyril Pellaton, Guillaume Cayla, Johanne Silvain, et al.
Journal of the American Heart Association
|
August 26, 2015
Infarct Size, Shock, and Heart Failure: Does Reperfusion Strategy Matter in Early Presenting Patients With ST-Segment Elevation Myocardial Infarction?
Jay Shavadia, Yinggan Zheng, Neda Dianati Maleki, et al.
Clinical Neurology and Neurosurgery
|
December 19, 2020
Impact of COVID-19 pandemic on patients with intracranial aneurysm rupture
Rabih Aboukaïs, Antoine Devalckeneer, Pierre Boussemart, et al.
Circulation. Cardiovascular Interventions
|
October 26, 2018
One-Year Survival After ST-Segment-Elevation Myocardial Infarction in Relation With Prehospital Administration of Dual Antiplatelet Therapy
Nicolas Danchin, Etienne Puymirat, Guillaume Cayla, et al.
American Heart Journal
|
November 7, 2015
Impact of prasugrel pretreatment and timing of coronary artery bypass grafting on clinical outcomes of patients with non-ST-segment elevation myocardial infarction: From the A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST-Elevation Myocardial Infarction (ACCOAST) study
Dariusz Dudek, Artur Dziewierz, Petr Widimsky, et al.
Archives of Cardiovascular Diseases
|
February 10, 2010
Functional decline in elderly patients presenting with acute coronary syndromes: impact on midterm outcome
Clémence Huerre, Aurélie Guiot, Sylvestre Maréchaux, et al.
Archives of Cardiovascular Diseases
|
July 27, 2010
Impact of polyvascular disease on baseline characteristics, management and mortality in acute myocardial infarction. The Alliance project
Anouk Meizels, David Messika Zeitoun, Vincent Bataille, et al.
Page
of 10